Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flexible-dose paliperidone ER in symptomatic adults with schizophrenia of less than 10 years' duration
2008-002384-13Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of paliperidone in schizophrenia, sponsored by Janssen Pharmaceutical. Primary endpoint: Change in total PANSS score. Started Sep 2008; status: completed.
02
Drugs
paliperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2008-002384-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002384-13.